Melanoma
Conference Coverage
Stage 3 melanoma attacked with immunotherapy and a virus-like particle
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
Latest News
A cost-effective de-escalation strategy in advanced melanoma
While the use of immunotherapies over the past decade has improved the prognosis for patients with advanced melanoma, these drugs come with a...
Latest News
Reminder that COVID-19 and cancer can be a deadly combo
“This analysis provides additional empirical evidence on the magnitude of risk to patients with cancer whose immune systems are often weakened...
News
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
News
BRAF/MEK combo shows long-term efficacy in melanoma
Despite positive results, immunotherapy likely remains the best choice for first-line treatment of BRAFV600 mutated advanced melanoma.
Conference Coverage
‘Smoking gun–level’ evidence found linking air pollution with lung cancer
The finding could lead to strategies for preventing lung cancer in nonsmokers exposed to high levels of foul air.
Latest News
Overall survival dips with vitamin D deficiency in melanoma
The research adds to existing evidence that “vitamin D levels can play an important and independent role in patients’ survival outcomes.”
Latest News
Devices to detect skin cancer: FDA advisers offer mixed views
There's been a swell in recent years in the number of publications related to the use of AI and machine learning, which could give rise to new...
